Looking to publish in Journal of Crohn s and Colitis? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginJournal of Crohn’s and Colitis is a gastroenterology journal published by Oxford University Press for the European Crohn's and Colitis Organisation (ECCO). It publishes research on Crohn’s disease, ulcerative colitis, inflammatory bowel disease, guidelines, consensus papers, reviews, and related content. The journal has a 2024 Impact Factor of 8.7 and a 2024 CiteScore of 15.6. Online ISSN: 1876-4479.
Looking to publish in Journal of Crohn s and Colitis? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Journal of Crohn s and Colitis accepts the following article types. Click on an article type to view submission instructions.
Original Article
Review Article
Viewpoint
Short Report
Letter To The Editor
Editorial
Recent Publications
Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease
Marie Truyens, Xenia Tolstoy, Giulio Calabrese, Anneline Cremer, Konrad Lewandowski, Konstantinos Argyriou, Ioannis Drygiannakis, Eathar Shakweh, Ploutarchos Pastras, Haluk Tarik Kani, María José García, Hannah Gordon, Davide Giuseppe Ribaldone, Konstantinos Karmiris, Carla Felice, Irene Moraleja Yudego, Andreas Blesl, Alessia Todeschini, Paola Balestrieri, Rafal Filip, Thibault Taelman, Nora Vladimirova, Georgios Michalopoulos, Mohamed Attauabi, Lieven Pouillon, Nurulamin Noor, Tommaso Innocenti, Sophie Vieujean, Tarkan Karakan, Manuel Barreiro-de Acosta, Giammarco Mocci, Maria Manuela Estevinho, Edoardo Vincenzo Savarino, Aranzazu Jauregui-Amezaga, Tom Holvoet, Christina Kapizioni, Gizem Dagci, Spyridon Vrakas, Charlotte R H Hedin, Olga Maria Nardone, Grażyna Rydzewska, Ioannis Koutroubakis, Ioannis Psaroudakis, Gabriele Dragoni, Jeroen Geldof, Gaëlle Varkas, Jo Lambert, Triana Lobatón
Experience-based reappraisal of the IBD-DCA histopathological scoring system
David Egong, Glen Doherty, Kieran Sheahan
2′-Fucosyllactose modulates gut microbiota and systemic metabolism in mild-to-moderate ulcerative colitis: a randomized crossover trial
James M Kennedy, Aminda N De Silva, Patricia Sanz Morales, Carlos G Poveda Turrado, Gemma E Walton, Glenn R Gibson
BRD4 contributes to the cytokine-induced acquisition of an IL-13RA2-positive inflammatory fibroblast phenotype
Rachele Frascatani, Mattia Alberto Serra, Andrea Iannucci, Marco Colella, Claudia Maresca, Irene Marafini, Elisabetta Lolli, Giorgia Sena, Andrea Divizia, Andrea Martina Guida, Giuseppe Sigismondo Sica, Giovanni Monteleone
Automated AI-based Mayo Endoscopic Scoring for ulcerative colitis across adult and pediatric cohorts from diverse populations
Kamal Hammouda, Rishi Dakarapu, Chathruckan Rajendra, Hyojeong Lee, Sahar Almahfouz Nasser, Sharmistha Rudra, Vasantha Kolachala, Caitlin Diefendorf, Irina Geiculescu, Sushma Maddipatla, Anant Madabhushi, Subra Kugathasan
Frequently asked questions
How long does it take to publish?
2025 median days from acceptance to publication: 21 days.
Reformat to Journal of Crohn s and Colitis using Livewrite PremiumIs a cover letter required?
A covering letter is expected when explaining the case for joint or equal first authorship.
Reformat to Journal of Crohn s and Colitis using Livewrite PremiumWhat are the publication costs?
Subscription journal with open access publishing options available, including publication through institutional Read and Publish agreements.
Reformat to Journal of Crohn s and Colitis using Livewrite Premium